Post-IPO Equity - Melinta Therapeutics
Investment Firm
Overview
Melinta Therapeutics is an antibiotics-focused company that develops and commercializes antibiotics to overcome drug-resistant infections.
Announced Date
Nov 29, 2012
Funding Type
Post Ipo Equity
Highlights
Location
United States, North America
Social
Investor Lead
N/A
Participant Investors
3
| Investor Name |
|---|
 Vatera Healthcare Partners |
 Warburg Pincus |
 ABS Ventures |
Round Details and Background
Melinta Therapeutics raised $67500000 on 2012-11-29 in Post-IPO Equity
Melinta Therapeutics is an antibiotics-focused company that develops and commercializes antibiotics to overcome drug-resistant infections.
Company Funding History
14
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Nov 29, 2012 |  Post-IPO Equity - Melinta Therapeutics | 4 | - | 67.5M |
| Feb 07, 2012 | Post-IPO Equity - Melinta Therapeutics | 1 | - | 3.0M |
| Jan 11, 2011 | Series E - Melinta Therapeutics | 1 | - | 20.0M |
| Jan 25, 2009 | Series D - Melinta Therapeutics | 8 | - | 25.0M |
Recent Activity
There is no recent news or activity for this profile.